649736-98-1 Usage
Description
4-Thiazolecarboxylic acid, 2-amino-5-propyl-, methyl ester (9CI) is a chemical compound that belongs to the thiazole carboxylic acid family. It is a derivative of thiazole with a propylamine substitution at the 2-amino position and a methyl ester group at the carboxylic acid portion of the molecule. 4-Thiazolecarboxylicacid,2-amino-5-propyl-,methylester(9CI) has potential applications in the field of medicinal chemistry and drug design due to its structural features and possible biological activities.
Uses
Used in Medicinal Chemistry:
4-Thiazolecarboxylic acid, 2-amino-5-propyl-, methyl ester (9CI) is used as a building block for the synthesis of various pharmaceutical compounds. Its unique structural features and potential biological activities make it a promising candidate for the development of new drugs.
Used in Drug Design:
4-Thiazolecarboxylic acid, 2-amino-5-propyl-, methyl ester (9CI) is used as a template for designing new drugs with specific therapeutic properties. Its structural features can be modified to optimize its pharmacological properties and improve its efficacy in treating various diseases.
Further studies and research are needed to explore the potential uses and properties of 4-Thiazolecarboxylic acid, 2-amino-5-propyl-, methyl ester (9CI) in different industries and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 649736-98-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,4,9,7,3 and 6 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 649736-98:
(8*6)+(7*4)+(6*9)+(5*7)+(4*3)+(3*6)+(2*9)+(1*8)=221
221 % 10 = 1
So 649736-98-1 is a valid CAS Registry Number.
649736-98-1Relevant articles and documents
Acylaminothiazole derivatives, preparation and therapeutic use thereof
-
Page/Page column 7, (2008/06/13)
This invention discloses and claims a compound conforming to the general formula (I): Wherein R1, R2, R′2, R3, R4 and R5 are as described herein. The compounds of the present invention exhibit an inhibitory effect on the production of β-amyloid peptide (β-A4) by inhibition of gamma protease. Therefore, the compounds of the present invention are useful in the treatment of pathologies such as senile dementia, Alzheimer's disease, Down's syndrome, Parkinson's disease, amyloid angiopathy and/or cerebrovascular disorders.